| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2746 | 2020 |
| Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 E Whittaker, A Bamford, J Kenny, M Kaforou, CE Jones, P Shah, ... Jama 324 (3), 259-269, 2020 | 2086 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1648 | 2020 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 1443 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 745* | 2021 |
| A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process R Harwood, B Allin, CE Jones, E Whittaker, P Ramnarayan, AV Ramanan, ... The Lancet Child & Adolescent Health 5 (2), 133-141, 2021 | 365 | 2021 |
| PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with … E Whittaker, A Bamford, J Kenny, M Kaforou, CE Jones, P Shah, ... JAMA 324 (3), 259-269, 2020 | 361 | 2020 |
| Respiratory syncytial virus vaccination during pregnancy and effects in infants SA Madhi, FP Polack, PA Piedra, FM Munoz, AA Trenholme, EAF Simões, ... New England Journal of Medicine 383 (5), 426-439, 2020 | 303 | 2020 |
| HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination C Evans, CE Jones, AJ Prendergast The Lancet infectious diseases 16 (6), e92-e107, 2016 | 291 | 2016 |
| The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement D Bumbacea, SM Arend, F Eyuboglu, JA Fishman, D Goletti, MG Ison, ... European Respiratory Journal 40 (4), 990-1013, 2012 | 277 | 2012 |
| Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants CE Jones, S Naidoo, C De Beer, M Esser, B Kampmann, AC Hesseling Jama 305 (6), 576-584, 2011 | 256 | 2011 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 213 | 2022 |
| Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a … SN Ladhani, NJ Andrews, J Southern, CE Jones, G Amirthalingam, ... Clinical infectious diseases 61 (11), 1637-1644, 2015 | 180 | 2015 |
| Maternal immunisation: collaborating with mother nature A Marchant, M Sadarangani, M Garand, N Dauby, V Verhasselt, L Pereira, ... The lancet infectious diseases 17 (7), e197-e208, 2017 | 176 | 2017 |
| Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy CR Wilcox, B Holder, CE Jones Frontiers in immunology 8, 292560, 2017 | 155 | 2017 |
| Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine KJ Hager, G Pérez Marc, P Gobeil, RS Diaz, G Heizer, C Llapur, ... New England journal of medicine 386 (22), 2084-2096, 2022 | 147 | 2022 |
| Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants B Lindsey, B Kampmann, C Jones Current opinion in infectious diseases 26 (3), 248-253, 2013 | 121 | 2013 |
| Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020 J Flood, J Shingleton, E Bennett, B Walker, Z Amin-Chowdhury, G Oligbu, ... The Lancet Regional Health–Europe 3, 2021 | 117 | 2021 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 110 | 2021 |
| Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014–15: a prospective surveillance study CP O'Sullivan, T Lamagni, D Patel, A Efstratiou, R Cunney, M Meehan, ... The Lancet Infectious Diseases 19 (1), 83-90, 2019 | 100 | 2019 |
